Psyence Biomedical Ltd.

PBM | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.10

-$0.42 (-6.44%)

At close: Sep 22, 2026, 4:00 PM ET

$6.16

+$0.06 (+0.98%)

After-hours: Sep 22, 2026, 7:58 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $124K

Enterprise Value $-7.07M

Beta 1.72

Average Volume 134.17K

Shares Outstanding (Diluted) 1.48M

Shares Change YoY -81.57%

Institutional Ownership 10.22%

Exchange NASDAQ

ISIN CA74449F4078

Price Performance

Price Change 1M 53.9%

Price Change 3M 126.8%

Price Change 6M 171.6%

Price Change YTD 32.0%

Price Change 1Y -75.8%

Price Change 3Y -99.9%

Price Change 5Y -99.9%

1M CAGR (ann.) 87.9%

1Y CAGR (ann.) -79.5%

5Y CAGR (ann.) N/A

All-Time CAGR -95.3%

Valuation

PE Ratio 1.86

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 0.01

P/FCF Ratio -0.12

P/Adj. FCF Ratio -0.12

P/OCF Ratio N/A

EV/Sales N/A

EV/EBIT 11.68

EV/EBITDA 11.73

EV/FCF 6.71

Earnings Yield 53.8%

FCF Yield -839.5%

Adj. FCF Yield -839.6%

Financial Health

Net Cash $7.2M

Total Debt $0

Cash & Short-Term Investments $7.2M

Total Assets $12.81M

Current Ratio 14.62

Quick Ratio 14.62

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -655.06

Altman Z-Score -5.67

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) 0.0%

Returns

Return on Assets -39.5%

Return on Equity -58.6%

Return on Invested Capital -36.8%

Return on Capital Employed -36.8%

Return on Tangible Assets -39.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 115.8%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -55.7%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jun 23, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-1.05M

Free Cash Flow $-1.05M

Adj. Free Cash Flow $-1.05M

FCF Per Share $0

OCF Per Share $0

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-2.35K

Operating Income $-2.66M

EBITDA $-602.96K

Net Income $-611.78K

EPS (Diluted) $3.55

Revenue / Employee N/A

Profit / Employee $-50.98K

Employees 12